CareDx(CDNA)
$81.17+0.40 (+0.50%)
CDNA
CareDx financials statements
$81.17
At close:+0.40 (+0.50%)
Want to see CDNA full AI Analyst Report?
CareDx (CDNA) Ratios
886 Followers
CareDx Ratios
CDNA's free cash flow for Q3 2026 was $11.10M. For the 2026 fiscal year, CDNA's free cash flow was decreased by $-1.61M and operating cash flow was $12.72M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.86 | 3.94 | 4.02 | 5.10 | 5.61 |
| Quick Ratio | 2.56 | 3.72 | 3.77 | 4.85 | 5.38 |
| Cash Ratio | 0.73 | 1.28 | 1.05 | 1.18 | 4.51 |
| Solvency Ratio | -0.01 | 0.64 | -0.83 | -0.54 | -0.19 |
| Operating Cash Flow Ratio | 0.47 | 0.43 | -0.24 | -0.33 | -0.25 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 147.00M | $ 239.22M | $ 108.22M | $ 275.77M | $ 332.62M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.06 | 0.07 | 0.07 | 0.04 |
| Debt-to-Equity Ratio | 0.09 | 0.07 | 0.13 | 0.09 | 0.05 |
| Debt-to-Capital Ratio | 0.08 | 0.07 | 0.12 | 0.08 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.36 | 1.30 | 1.79 | 1.26 | 1.22 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.49 | 0.54 | 0.64 | 0.73 | 0.41 |
| Net Debt to EBITDA | 8.43 | 2.54 | 0.56 | 0.83 | 18.34 |
| Profitability Margins | |||||
| Gross Profit Margin | 67.55% | 67.16% | 63.61% | 65.13% | 67.14% |
| EBIT Margin | -6.60% | -16.10% | -37.36% | -24.00% | -10.03% |
| EBITDA Margin | -1.23% | -10.18% | -30.29% | -19.03% | -6.02% |
| Operating Profit Margin | -6.60% | 12.21% | -72.55% | -24.00% | -10.03% |
| Pretax Profit Margin | -5.55% | 15.84% | -67.83% | -23.69% | -10.83% |
| Net Profit Margin | -5.62% | 15.74% | -67.88% | -23.81% | -10.34% |
| Continuous Operations Profit Margin | -5.62% | 15.74% | -67.88% | -23.81% | -10.34% |
| Net Income Per EBT | 101.29% | 99.41% | 100.07% | 100.50% | 95.56% |
| EBT Per EBIT | 84.09% | 129.67% | 93.50% | 98.71% | 107.95% |
| Return on Assets (ROA) | -5.17% | 10.70% | -40.76% | -14.11% | -5.41% |
| Return on Equity (ROE) | -7.05% | 13.89% | -72.81% | -17.78% | -6.58% |
| Return on Capital Employed (ROCE) | -7.75% | 10.15% | -52.31% | -16.54% | -6.07% |
| Return on Invested Capital (ROIC) | -7.60% | 9.94% | -51.52% | -16.34% | -5.76% |
| Return on Tangible Assets | -6.26% | 12.74% | -49.97% | -16.57% | -6.40% |
| Earnings Yield | -2.13% | 4.65% | -29.49% | -12.59% | -1.29% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.91 | 5.17 | 5.49 | 4.85 | 4.96 |
| Payables Turnover | 12.34 | 14.26 | 7.92 | 11.29 | 7.30 |
| Inventory Turnover | 4.61 | 5.62 | 5.24 | 5.83 | 5.67 |
| Fixed Asset Turnover | 6.81 | 5.77 | 4.30 | 4.58 | 7.40 |
| Asset Turnover | 0.92 | 0.68 | 0.60 | 0.59 | 0.52 |
| Working Capital Turnover Ratio | 1.77 | 1.34 | 1.02 | 0.96 | 1.06 |
| Cash Conversion Cycle | 90.48 | 109.99 | 90.10 | 105.43 | 88.02 |
| Days of Sales Outstanding | 40.97 | 70.65 | 66.48 | 75.22 | 73.59 |
| Days of Inventory Outstanding | 79.09 | 64.93 | 69.68 | 62.56 | 64.41 |
| Days of Payables Outstanding | 29.58 | 25.59 | 46.06 | 32.34 | 49.99 |
| Operating Cycle | 120.06 | 135.58 | 136.16 | 137.77 | 138.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.79 | 0.72 | -0.34 | -0.47 | -0.37 |
| Free Cash Flow Per Share | 0.68 | 0.60 | -0.51 | -0.93 | -0.76 |
| Dividend Paid and CapEx Coverage Ratio | 7.11 | 5.87 | -1.99 | -1.04 | -0.95 |
| Capital Expenditure Coverage Ratio | 7.11 | 5.87 | -1.99 | -1.04 | -0.95 |
| Operating Cash Flow Coverage Ratio | 1.60 | 1.34 | -0.54 | -0.65 | -0.90 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.11 | -0.07 | -0.08 | -0.07 |
| Free Cash Flow Yield | 3.60% | 2.79% | -4.28% | -8.15% | -1.66% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -47.10 | 21.41 | -3.39 | -7.94 | -77.49 |
| Price-to-Sales (P/S) Ratio | 2.64 | 3.39 | 2.30 | 1.89 | 8.02 |
| Price-to-Book (P/B) Ratio | 3.31 | 2.99 | 2.47 | 1.41 | 5.10 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 27.80 | 35.80 | -23.35 | -12.27 | -60.07 |
| Price-to-Operating Cash Flow Ratio | 23.89 | 29.70 | -35.09 | -24.11 | -123.14 |
| Price-to-Earnings Growth (PEG) Ratio | 0.34 | -0.17 | -0.02 | -0.06 | -1.63 |
| Enterprise Value Multiple | -207.24 | -30.70 | -7.03 | -9.11 | -114.84 |
| Enterprise Value | 964.70M | 1.04B | 597.20M | 557.48M | 2.05B |
| EV to EBITDA | -207.24 | -30.70 | -7.03 | -9.11 | -114.84 |
| EV to Sales | 2.54 | 3.13 | 2.13 | 1.73 | 6.91 |
| EV to Free Cash Flow | 26.71 | 33.06 | -21.62 | -11.25 | -51.80 |
| EV to Operating Cash Flow | 22.95 | 27.43 | -32.48 | -22.09 | -106.19 |
| Tangible Book Value Per Share | 4.33 | 5.68 | 3.26 | 6.57 | 7.25 |
| Shareholders’ Equity Per Share | 5.69 | 7.17 | 4.86 | 8.08 | 8.92 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.01 | -0.00 | -0.00 | 0.04 |
| Revenue Per Share | 7.13 | 6.32 | 5.21 | 6.03 | 5.67 |
| Net Income Per Share | -0.40 | 1.00 | -3.54 | -1.44 | -0.59 |
| Tax Burden | 1.01 | 0.99 | 1.00 | 1.00 | 0.96 |
| Interest Burden | 0.84 | -0.98 | 1.82 | 0.99 | 1.08 |
| Research & Development to Revenue | 0.19 | 0.22 | 0.29 | 0.28 | 0.26 |
| SG&A to Revenue | 0.55 | 0.62 | 0.42 | 0.31 | 0.25 |
| Stock-Based Compensation to Revenue | 0.09 | 0.20 | 0.18 | 0.14 | 0.12 |
| Income Quality | -1.97 | 0.72 | 0.10 | 0.33 | 0.63 |
Currency in USD
